Celltrion Expands Access to YUFLYMA (adalimumab-aaty) | Goodwin
On October 5, Celltrion Healthcare Co. announced that it has signed a contract with Ventegra, a major U.S. Medical Benefits Manager (MBM) “who administers pharmacy benefits through its...
Source: jdsupra.com